Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants

Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2021-04, Vol.12, p.677572
Hauptverfasser: Totsune, Eriko, Nakano, Tomohiro, Moriya, Kunihiko, Sato, Daichi, Suzuki, Dai, Miura, Akinobu, Katayama, Saori, Niizuma, Hidetaka, Kanno, Junko, van Zelm, Menno C, Imai, Kohsuke, Kanegane, Hirokazu, Sasahara, Yoji, Kure, Shigeo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 677572
container_title Frontiers in immunology
container_volume 12
creator Totsune, Eriko
Nakano, Tomohiro
Moriya, Kunihiko
Sato, Daichi
Suzuki, Dai
Miura, Akinobu
Katayama, Saori
Niizuma, Hidetaka
Kanno, Junko
van Zelm, Menno C
Imai, Kohsuke
Kanegane, Hirokazu
Sasahara, Yoji
Kure, Shigeo
description Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was . We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.
doi_str_mv 10.3389/fimmu.2021.677572
format Article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8072023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9715a48c5f38436bbd65b95756762c07</doaj_id><sourcerecordid>33912197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-5a82ed825daaae62c6a504c114b7f1613cec1985c7d5aba034ea0e503b2c157b3</originalsourceid><addsrcrecordid>eNpVkc9O3DAQh6OqqCDgAXqp_ALZ-k8cJz1UoqHAStsiIdqrNXYmW6MkjuwEaXl6DEsRzMWj8fy-OXxZ9pnRlRBV_bVzw7CsOOVsVSolFf-QHbGyLHLBefHxTX-YncZ4R1MVtRBCfsoOhagZZ7U6ymIDEckNTj7M38h67GCcXY_59RhxJhdLP7gxjcjtbkLCyLkDgzNG8gv73s1LJA0sEVtiduS3v8eeNH6Y_DK25CrtBf-w2_q0tbn5cUb-QnCJFU-ygw76iKcv73H25-LnbXOVb64v183ZJrdFXc25hIpjW3HZAgCW3JYgaWEZK4zqWMmERcvqSlrVSjBARYFAUVJhuGVSGXGcrffc1sOdnoIbIOy0B6efBz5sNYTZ2R51rZiEorKyE1UhSmPaUppaKlmqdJiqxPq-Z02LGbC1OM4B-nfQ9z-j-6e3_l5XVCVHIgHYHmCDjzFg95plVD8J1c9C9ZNQvReaMl_eHn1N_NcnHgEIIZ5s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Totsune, Eriko ; Nakano, Tomohiro ; Moriya, Kunihiko ; Sato, Daichi ; Suzuki, Dai ; Miura, Akinobu ; Katayama, Saori ; Niizuma, Hidetaka ; Kanno, Junko ; van Zelm, Menno C ; Imai, Kohsuke ; Kanegane, Hirokazu ; Sasahara, Yoji ; Kure, Shigeo</creator><creatorcontrib>Totsune, Eriko ; Nakano, Tomohiro ; Moriya, Kunihiko ; Sato, Daichi ; Suzuki, Dai ; Miura, Akinobu ; Katayama, Saori ; Niizuma, Hidetaka ; Kanno, Junko ; van Zelm, Menno C ; Imai, Kohsuke ; Kanegane, Hirokazu ; Sasahara, Yoji ; Kure, Shigeo</creatorcontrib><description>Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was . We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2021.677572</identifier><identifier>PMID: 33912197</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>CTLA-4 deficiency ; Immunology ; infantile-onset fulminant type 1 diabetes mellitus ; LRBA deficiency ; refractory autoimmune cytopenia ; transposable elements (TE)</subject><ispartof>Frontiers in immunology, 2021-04, Vol.12, p.677572</ispartof><rights>Copyright © 2021 Totsune, Nakano, Moriya, Sato, Suzuki, Miura, Katayama, Niizuma, Kanno, van Zelm, Imai, Kanegane, Sasahara and Kure.</rights><rights>Copyright © 2021 Totsune, Nakano, Moriya, Sato, Suzuki, Miura, Katayama, Niizuma, Kanno, van Zelm, Imai, Kanegane, Sasahara and Kure 2021 Totsune, Nakano, Moriya, Sato, Suzuki, Miura, Katayama, Niizuma, Kanno, van Zelm, Imai, Kanegane, Sasahara and Kure</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-5a82ed825daaae62c6a504c114b7f1613cec1985c7d5aba034ea0e503b2c157b3</citedby><cites>FETCH-LOGICAL-c498t-5a82ed825daaae62c6a504c114b7f1613cec1985c7d5aba034ea0e503b2c157b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072023/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072023/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33912197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Totsune, Eriko</creatorcontrib><creatorcontrib>Nakano, Tomohiro</creatorcontrib><creatorcontrib>Moriya, Kunihiko</creatorcontrib><creatorcontrib>Sato, Daichi</creatorcontrib><creatorcontrib>Suzuki, Dai</creatorcontrib><creatorcontrib>Miura, Akinobu</creatorcontrib><creatorcontrib>Katayama, Saori</creatorcontrib><creatorcontrib>Niizuma, Hidetaka</creatorcontrib><creatorcontrib>Kanno, Junko</creatorcontrib><creatorcontrib>van Zelm, Menno C</creatorcontrib><creatorcontrib>Imai, Kohsuke</creatorcontrib><creatorcontrib>Kanegane, Hirokazu</creatorcontrib><creatorcontrib>Sasahara, Yoji</creatorcontrib><creatorcontrib>Kure, Shigeo</creatorcontrib><title>Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was . We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.</description><subject>CTLA-4 deficiency</subject><subject>Immunology</subject><subject>infantile-onset fulminant type 1 diabetes mellitus</subject><subject>LRBA deficiency</subject><subject>refractory autoimmune cytopenia</subject><subject>transposable elements (TE)</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkc9O3DAQh6OqqCDgAXqp_ALZ-k8cJz1UoqHAStsiIdqrNXYmW6MkjuwEaXl6DEsRzMWj8fy-OXxZ9pnRlRBV_bVzw7CsOOVsVSolFf-QHbGyLHLBefHxTX-YncZ4R1MVtRBCfsoOhagZZ7U6ymIDEckNTj7M38h67GCcXY_59RhxJhdLP7gxjcjtbkLCyLkDgzNG8gv73s1LJA0sEVtiduS3v8eeNH6Y_DK25CrtBf-w2_q0tbn5cUb-QnCJFU-ygw76iKcv73H25-LnbXOVb64v183ZJrdFXc25hIpjW3HZAgCW3JYgaWEZK4zqWMmERcvqSlrVSjBARYFAUVJhuGVSGXGcrffc1sOdnoIbIOy0B6efBz5sNYTZ2R51rZiEorKyE1UhSmPaUppaKlmqdJiqxPq-Z02LGbC1OM4B-nfQ9z-j-6e3_l5XVCVHIgHYHmCDjzFg95plVD8J1c9C9ZNQvReaMl_eHn1N_NcnHgEIIZ5s</recordid><startdate>20210412</startdate><enddate>20210412</enddate><creator>Totsune, Eriko</creator><creator>Nakano, Tomohiro</creator><creator>Moriya, Kunihiko</creator><creator>Sato, Daichi</creator><creator>Suzuki, Dai</creator><creator>Miura, Akinobu</creator><creator>Katayama, Saori</creator><creator>Niizuma, Hidetaka</creator><creator>Kanno, Junko</creator><creator>van Zelm, Menno C</creator><creator>Imai, Kohsuke</creator><creator>Kanegane, Hirokazu</creator><creator>Sasahara, Yoji</creator><creator>Kure, Shigeo</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210412</creationdate><title>Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants</title><author>Totsune, Eriko ; Nakano, Tomohiro ; Moriya, Kunihiko ; Sato, Daichi ; Suzuki, Dai ; Miura, Akinobu ; Katayama, Saori ; Niizuma, Hidetaka ; Kanno, Junko ; van Zelm, Menno C ; Imai, Kohsuke ; Kanegane, Hirokazu ; Sasahara, Yoji ; Kure, Shigeo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-5a82ed825daaae62c6a504c114b7f1613cec1985c7d5aba034ea0e503b2c157b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CTLA-4 deficiency</topic><topic>Immunology</topic><topic>infantile-onset fulminant type 1 diabetes mellitus</topic><topic>LRBA deficiency</topic><topic>refractory autoimmune cytopenia</topic><topic>transposable elements (TE)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Totsune, Eriko</creatorcontrib><creatorcontrib>Nakano, Tomohiro</creatorcontrib><creatorcontrib>Moriya, Kunihiko</creatorcontrib><creatorcontrib>Sato, Daichi</creatorcontrib><creatorcontrib>Suzuki, Dai</creatorcontrib><creatorcontrib>Miura, Akinobu</creatorcontrib><creatorcontrib>Katayama, Saori</creatorcontrib><creatorcontrib>Niizuma, Hidetaka</creatorcontrib><creatorcontrib>Kanno, Junko</creatorcontrib><creatorcontrib>van Zelm, Menno C</creatorcontrib><creatorcontrib>Imai, Kohsuke</creatorcontrib><creatorcontrib>Kanegane, Hirokazu</creatorcontrib><creatorcontrib>Sasahara, Yoji</creatorcontrib><creatorcontrib>Kure, Shigeo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Totsune, Eriko</au><au>Nakano, Tomohiro</au><au>Moriya, Kunihiko</au><au>Sato, Daichi</au><au>Suzuki, Dai</au><au>Miura, Akinobu</au><au>Katayama, Saori</au><au>Niizuma, Hidetaka</au><au>Kanno, Junko</au><au>van Zelm, Menno C</au><au>Imai, Kohsuke</au><au>Kanegane, Hirokazu</au><au>Sasahara, Yoji</au><au>Kure, Shigeo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2021-04-12</date><risdate>2021</risdate><volume>12</volume><spage>677572</spage><pages>677572-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was . We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>33912197</pmid><doi>10.3389/fimmu.2021.677572</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2021-04, Vol.12, p.677572
issn 1664-3224
1664-3224
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8072023
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects CTLA-4 deficiency
Immunology
infantile-onset fulminant type 1 diabetes mellitus
LRBA deficiency
refractory autoimmune cytopenia
transposable elements (TE)
title Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A56%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20Report:%20Infantile-Onset%20Fulminant%20Type%201%20Diabetes%20Mellitus%20Caused%20by%20Novel%20Compound%20Heterozygous%20LRBA%20Variants&rft.jtitle=Frontiers%20in%20immunology&rft.au=Totsune,%20Eriko&rft.date=2021-04-12&rft.volume=12&rft.spage=677572&rft.pages=677572-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2021.677572&rft_dat=%3Cpubmed_doaj_%3E33912197%3C/pubmed_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33912197&rft_doaj_id=oai_doaj_org_article_9715a48c5f38436bbd65b95756762c07&rfr_iscdi=true